Endpoints News 2025年12月9日 #SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer
Endpoints News 2025年12月9日 #ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped
Endpoints News 2025年12月8日 #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
Endpoints News 2025年12月8日 Dyne says Duchenne drug succeeds in pivotal study, heads to FDA for approval
Endpoints News 2025年12月8日 Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC
Endpoints News 2025年12月8日 #ASH25: Kura, Syndax detail data for rival menin inhibitors as both eye earlier use in AML
Endpoints News 2025年12月8日 Structure Therapeutics’ obesity pill stacks up with Novo and Lilly; Ascletis also reports early results
Endpoints News 2025年12月7日 #ASH25: Star Therapeutics details early data for blood disorder shot, weighs IPO
Endpoints News 2025年12月6日 #ASH25: AstraZeneca's dual-targeting CAR-T sees similar responses in Western patients as in China
Endpoints News 2025年12月6日 #ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens